Issue link: https://www.e-digitaleditions.com/i/1056686
28 December 2018 Inhalation Lactose for dry powder inhalation. Meggle's new InhaLac ® 160 lactose for dry powder inhalation is characterized by a median particle size of approximately 110 µm, which ranges between Meggle's coarser lactose InhaLac ® 120 and finer lactose InhaLac ® 230. Benefits of InhaLac include a dedicated produc- tion process, highly controlled powder characteristics. Meggle Excipients & Technology US: +1 844-4MEGGLE www.meggle-pharma.com Off-the-shelf generic devices Merxin is a generic device supplier. We develop and provide inhalers that have popular device platforms so you can speed up product development and filing, reduce cost, reduce risk and increase success. The Merxin MRX001 is a multidose blister dry powder inhaler (DPI), MRX003 is a capsule DPI and MRX004 is a soft mist inhaler. Merxin UK: +44 1223 787300 www.merxin.com Development and manufacturing capabilities Recipharm and Sanofi have completed the transfer of Sanofi's Holmes Chapel, UK site to leading pharma- ceutical CDMO, Recipharm. e new facility, which includes development and manufacturing capabilities for novel respiratory products, complements the inha- lation development expertise offered by the Recipharm team in Research Triangle Park, North Carolina, US. e prime technologies manufactured at the facil- ity include metered dose inhalers and nasal sprays. e facility also houses several development suites specifi- cally for dry powder and other inhalation technologies. Recipharm Sweden: +46 8 602 52 00 www.recipharm.com eMDI smart connected inhaler H&T Presspart, a leading manufacturer of MDI devices, has launched the eMDI, a market-ready, fully embedded, intuitive, connected metered dose inhaler. e eMDI seamlessly integrates with the BreatheSmart health app from Cohero Health, with the eMDI helping improve patient adherence. As a fully functioning, mar- ket-ready device, it can help pharmaceutical manufac- turers rapidly and cost-efficiently bring excellent care to patients with asthma and COPD. H&T Presspart UK: +44 1254 584131 www.presspart.com